A new rapid test panel for HIV, hepatitis B, and syphilis screening in pregnant women was unveiled at the International AIDS Society (IAS) Conference on HIV Science in Kigali on July 15. The test, ...

A newly approved HIV prevention drug, lenacapavir, is set to be introduced in at least nine countries in early 2026, and Rwanda could be among the first to deploy it, government and World Health ...

As science soars with game-changing HIV tools, a funding crisis threatens to ground progress "We come together at a pivotal time for the HIV response, one defined by both incredible scientific ...

A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and developing AIDS should be made available "immediately" at pharmacies, clinics and ...

IAS 2025, the 13th IAS Conference on HIV Science, opened today with a call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global funding challenges. Four ...

Trusted reporting has helped ST readers navigate fear and facts, from the “Spanish” flu to Covid-19. Read more at straitstimes.com. Read more at straitstimes.com.

In the mid-1990s, my then-husband passed away from complications of HIV/AIDS. From the time he was diagnosed until he died, all of us, friends and family, but most of all, him, knew how it would end.

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool ...

As expected, the new recommendations that the World Health Organization (WHO) issued for HIV and sexually transmitted ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection.

Senate Republicans are putting the popularity of Department of Government Efficiency spending cuts to the test this week ...